statistiche ricercatore

Continente	#
NA - Nord America	836
AS - Asia	549
EU - Europa	531
SA - Sud America	158
Continente sconosciuto - Info sul continente non disponibili	37
AF - Africa	19
OC - Oceania	5
Totale	2.135

Nazione	#
US - Stati Uniti d'America	794
SG - Singapore	274
IT - Italia	167
BR - Brasile	123
CN - Cina	96
SE - Svezia	96
FR - Francia	73
VN - Vietnam	54
DE - Germania	47
PL - Polonia	37
GB - Regno Unito	23
IE - Irlanda	23
IN - India	20
ID - Indonesia	19
JP - Giappone	16
HK - Hong Kong	14
RU - Federazione Russa	14
MX - Messico	13
CA - Canada	12
AR - Argentina	11
BD - Bangladesh	9
UA - Ucraina	9
CH - Svizzera	7
AT - Austria	6
ES - Italia	6
IQ - Iraq	6
NL - Olanda	6
PK - Pakistan	6
TR - Turchia	6
AU - Australia	5
CL - Cile	5
KR - Corea	5
VE - Venezuela	5
AZ - Azerbaigian	4
CO - Colombia	4
DO - Repubblica Dominicana	4
FI - Finlandia	4
KE - Kenya	4
PY - Paraguay	4
ZA - Sudafrica	4
JO - Giordania	3
LT - Lituania	3
PR - Porto Rico	3
SC - Seychelles	3
UY - Uruguay	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
CI - Costa d'Avorio	2
EC - Ecuador	2
MA - Marocco	2
NG - Nigeria	2
NI - Nicaragua	2
RO - Romania	2
SA - Arabia Saudita	2
TW - Taiwan	2
AM - Armenia	1
BG - Bulgaria	1
BH - Bahrain	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EE - Estonia	1
GM - Gambi	1
GP - Guadalupe	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
IL - Israele	1
IR - Iran	1
JM - Giamaica	1
KZ - Kazakistan	1
MY - Malesia	1
NP - Nepal	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
SN - Senegal	1
SV - El Salvador	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.100

Nome	#
R&D investments, financing constraints, exporting and productivity	250
What exactly is public in a public good game? A lab-in-the field experiment	241
What does a young cheater look like? An innovative approach	157
R&D and market size: who benefits from orphan drug regulation?	145
DETERMINANTS AND EFFECTS OF INNOVATION: AN EMPIRICAL ANALYSIS	145
The impact of Managed Entry Agreements on pharmaceutical prices	137
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence	132
When the two ends meet: an experiment on cooperation across the Italian North-South divide	129
Optimizing Tax Administration Policies with Machine Learning	121
Lies have long legs. Cheating, public scrutiny and loyalty in teams	117
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector	115
Audit Publicity and Tax Compliance: A Natural Experiment	96
When the two ends meet: an experiment on cooperation and social capital	90
The impact of social pressure on tax compliance: A field experiment	90
COVID-19: R0 is lower where outbreak is larger	89
L’expérience camerounaise d’accès aux thérapies de seconde ligne	81
Totale	2.135

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	111	0	0	0	0	18	0	4	31	7	6	26	19
2022/2023	260	30	22	19	43	13	38	6	24	30	16	13	6
2023/2024	139	8	38	18	3	7	18	8	0	3	5	17	14
2024/2025	358	9	8	20	11	33	10	10	3	91	39	76	48
2025/2026	617	90	27	44	84	77	24	121	40	40	45	16	9
2026/2027	293	26	35	37	181	14	0	0	0	0	0	0	0
Totale													2.135

IRIS UniCatt